1. Evidence of association between tocilizumab and cutaneous vasculitis

   Review 26 September 2020 Pages: 1 - 1

2. FDA says benefits of lorcaserin do not outweigh risk of cancer

   Clinical study 26 September 2020 Pages: 2 - 2

3. Pirfenidone linked with risk of drug-induced liver injury

   News item 26 September 2020 Pages: 3 - 3

4. Thyroid tablets recalled for subpotency

   Media release 26 September 2020 Pages: 4 - 4

5. Dabigatran cost effective in AF but stroke and bleeding risk important

   Clinical study 26 September 2020 Pages: 5 - 5

6. Fruquintinib in metastatic colorectal cancer: "acceptable" safety profile

   Clinical study 26 September 2020 Pages: 6 - 6

7. High cumulative exposure to oral corticosteroids for asthma a concern

   Clinical study 26 September 2020 Pages: 7 - 7

8. Low risk of extravasation injury from IV infusion of norepinephrine

   Clinical study 26 September 2020 Pages: 8 - 8

9. Opioid analgesic use after cancer treatment increases risk of AEs

   Clinical study 26 September 2020 Pages: 9 - 9

10. PPI use affects outcomes in urothelial cancer treated with atezolizumab

    Clinical study 26 September 2020 Pages: 10 - 10

11. Vascular aging long-term effect of cisplatin-based chemotherapy

    Clinical study 26 September 2020 Pages: 11 - 11

12. Other adverse reaction research

    News item 26 September 2020 Pages: 12 - 12

13. Acenocoumarol

    Case report 26 September 2020 Pages: 13 - 13

14. Acetylcysteine/paracetamol

    Case report 26 September 2020 Pages: 14 - 14

15. Aciclovir

    Case report 26 September 2020 Pages: 15 - 15

16. Aciclovir

    Case report 26 September 2020 Pages: 16 - 16

17. Aciclovir/ciclosporin

    Case report 26 September 2020 Pages: 17 - 17

18. Acitretin

    Case report 26 September 2020 Pages: 18 - 18

19. Adalimumab

    Case report 26 September 2020 Pages: 19 - 19

20. Adalimumab

    Case report 26 September 2020 Pages: 20 - 20

21. Adalimumab

    Case report 26 September 2020 Pages: 21 - 21

22. Adalimumab

    Case report 26 September 2020 Pages: 22 - 22

23. Adalimumab/infliximab/vedolizumab

    Case report 26 September 2020 Pages: 23 - 23

24. Adalimumab/methotrexate

    Case report 26 September 2020 Pages: 24 - 24

25. Afatinib/osimertinib

    Case report 26 September 2020 Pages: 25 - 25

26. Albumin human/amlodipine/methylthioninium chloride

    Case report 26 September 2020 Pages: 26 - 26

27. Alcohol

    Case report 26 September 2020 Pages: 27 - 27

28. Alemtuzumab

    Case report 26 September 2020 Pages: 28 - 28

29. Alemtuzumab/anakinra/ruxolitinib

    Case report 26 September 2020 Pages: 29 - 29

30. Alendronic acid

    Case report 26 September 2020 Pages: 30 - 30

31. Allopurinol

    Case report 26 September 2020 Pages: 31 - 31

32. Allopurinol

    Case report 26 September 2020 Pages: 32 - 32

33. Alprazolam/lorazepam withdrawal

    Case report 26 September 2020 Pages: 33 - 33

34. Alprostadil

    Case report 26 September 2020 Pages: 34 - 34

35. Amiloride

    Case report 26 September 2020 Pages: 35 - 35

36. Amiodarone

    Case report 26 September 2020 Pages: 36 - 36

37. Amiodarone

    Case report 26 September 2020 Pages: 37 - 37

38. Amitriptyline/antipsychotics/linezolid

    Case report 26 September 2020 Pages: 38 - 38

39. Amlodipine

    Case report 26 September 2020 Pages: 39 - 39

40. Amlodipine/glucose/insulin

    Case report 26 September 2020 Pages: 40 - 40

41. Amoxicillin

    Case report 26 September 2020 Pages: 41 - 41

42. Amoxicillin/clavulanic acid/cefazolin/prednisolone

    Case report 26 September 2020 Pages: 42 - 42

43. Amoxicillin/clavulanic acid/cefepime/ceftriaxone

    Case report 26 September 2020 Pages: 43 - 43

44. Amphotericin-B liposomal

    Case report 26 September 2020 Pages: 44 - 44

45. Amygdalin/ascorbic-acid

    Case report 26 September 2020 Pages: 45 - 45

46. Anabolic steroids

    Case report 26 September 2020 Pages: 46 - 46

47. Anaesthetics/oxytocin

    Case report 26 September 2020 Pages: 47 - 47

48. Anakinra/tocilizumab

    Case report 26 September 2020 Pages: 48 - 48

49. Analgesics/antispastics

    Case report 26 September 2020 Pages: 49 - 49

50. Anti-neoplastics

    Case report 26 September 2020 Pages: 50 - 50